Search Results for "covid-19 vaccine" "adverse events"

Yellow Card scheme for adverse events does not suggest any new side effects of COVID-19 vaccines

Adverse event reporting systems, such as the Yellow Card scheme in the U.K. or VAERS in the U.S., are designed to help health authorities monitor the safety of medical products such as the COVID-19 vaccines. However, the databases contain unverified information and cannot demonstrate that COVID-19 vaccines caused adverse events. The reports can be a starting point for a detailed investigation into potential side effects, which happened for rare cases of blood clotting and anaphylaxis. Overall, the U.K. regulatory body, the MHRA, still concludes that the benefits of the COVID-19 vaccines outweigh their known risks.

VAERS reports of adverse events in people who received COVID-19 vaccines don’t demonstrate that these events were caused by the vaccines; evidence does not indicate COVID-19 vaccines caused Bell’s palsy and deaths

Both COVID-19 vaccines approved for emergency use by the U.S. Food and Drug Administration were thoroughly reviewed for safety and efficacy before approval. The U.S. Adverse Events Reporting System (VAERS) enables the public and healthcare providers to report adverse events that occur after vaccination. It serves as an early warning system for potential problems with vaccines. However, determining whether there is a causal link requires further investigation into these reports. VAERS data only tells us that an adverse event occurred after vaccination; on its own it cannot prove that vaccines caused the adverse event.

The human metapneumovirus (hMPV) has been circulating for decades and isn’t a side effect of the Pfizer-BioNTech COVID-19 vaccine

Human metapneumovirus (hMPV) is a virus that infects the upper respiratory tract and causes common colds. In vulnerable groups, such as young children, the elderly, or immunosuppressed individuals, it can occasionally lead to complications like pneumonia. hMPV has been circulating for decades, and there is no data that establishes a causal relationship between hMPV infections and COVID-19 vaccines.

Flawed analysis by Peter McCullough and others used to promote baseless claim that brain blood clots “112,000% more likely” after COVID-19 vaccine than flu vaccine

Since 2021, certain COVID-19 vaccines, specifically the viral vector COVID-19 vaccines, have been linked to a rare blood clotting problem known as thrombosis with thrombocytopenia syndrome. But COVID-19 mRNA vaccines aren’t associated with the same risk. COVID-19 vaccines are highly effective at reducing the risk of severe disease and death. Getting COVID-19 is associated with a much greater risk of blood clots than getting the vaccine. On balance, the vaccines’ benefits outweigh their risks.

Peter McCullough misleads again about the benefits and risks of COVID-19 vaccines in viral interview

COVID-19 vaccines are the safest way of reducing the likelihood of getting severely ill or dying from COVID-19. However, they are associated with some risks; for example, viral vector vaccines are associated with rare cases of blood clotting, and mRNA COVID-19 vaccines are associated with a slightly increased risk of heart inflammation in young males. But COVID-19 itself carries a much higher risk of developing blood clots and cardiovascular problems than vaccination. By lowering these risks, the benefits of COVID-19 vaccination outweigh the small risk of serious side effects.

Contrary to headline by The People’s Voice, COVID-19 vaccines aren’t “killing millions” but instead prevented deaths

COVID-19 vaccines reduce the risk of severe COVID-19 and various complications with the disease, and are estimated to have saved millions of lives worldwide. All vaccines can cause side effects. However, most side effects from COVID-19 vaccination are generally mild and disappear within a few days. While cases of serious side effects from COVID-19 vaccines do exist, they are extremely infrequent and don’t outweigh the benefits of vaccination.

COVID-19 vaccines lowered excess deaths during the pandemic, contrary to headline by the Daily Telegraph

The COVID-19 vaccines are estimated to have saved 14 million lives worldwide within their first year. While there are extremely rare instances of heart inflammation and blood clots following vaccination, these risks are far outweighed by the lives saved. While excess deaths were observed from 2020 to 2022, the vast majority are due directly or indirectly to COVID-19 itself. The data that we have shows no association with the COVID-19 vaccines.

Very rare cases of blood clots linked to the Oxford-AstraZeneca COVID-19 vaccine are well-known and have been publicly recognized since 2021

The Oxford-AstraZeneca COVID-19 vaccine was one of the few tools available to reduce the risk of serious illness and death at the initial stages of the COVID-19 pandemic. The vaccine underwent rigorous testing to ensure it was safe and effective. In 2021, a rare but serious condition involving blood clots with low platelet level—known as thrombosis with thrombocytopenia—was associated with the vaccine. However, the chance that this condition will occur after vaccination is very low, and the benefits of vaccination outweigh this small risk.

Claim that myocarditis from COVID-19 vaccines carries serious risk of death is based on flawed study

Studies have shown that people vaccinated against COVID-19 are less likely to develop severe disease, require hospitalization, and die from COVID-19 compared to unvaccinated people. While COVID-19 vaccines are associated with a slightly elevated risk of myocarditis and a particular blood clotting disorder, it is COVID-19 that is associated with a greater risk of these illnesses and other complications. On balance, the evidence gathered so far by studies shows that the benefits of COVID-19 vaccination outweigh the risks, not the other way around.